Saltar al contenido
Merck

[Lerkanidipin: evolution of dihydropyridine calcium antagonists continues].

Kardiologiia (2012-12-15)
V V Fomin, A A Svistunov
RESUMEN

We discuss the clinical studies on the efficacy and tolerability of lerkanidipine in arterial hypertension.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Lercanidipine hydrochloride, ≥98% (HPLC)